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1. Introduction 
Tryptophan is an essential amino acid and a synthetic and 
biosynthetic precursor for many natural products of alkaloid and 
non-ribosomal peptide origin. These include the anticancer agent 
staurosporine1 and diazonamide A,2 indole alkaloids such as 
vindoline3 and vinblastine,3 and antibiotics such as daptamycin4 
and the calcium-dependent antibiotic (CDA).5 Furthermore, 
tryptophans are essential to the structure and function of proteins 
and, though present in proteins at only 1.2% frequency, 
tryptophan is largely attributed to conferring UV absorbance and 
fluorescence in these biomolecules.6 The ability to functionalise 
tryptophan is attractive as it provides a handle for selectively 
tuning the properties of the free amino acid or the amino acid as a 
component of a natural product or a peptide. We have previously 
demonstrated a new paradigm in natural product analogue 
generation, Genochemetics,7 in which gene installation enables 
the biosynthetic introduction of a chemically orthogonal handle 
into a natural product, enabling selective synthetic 
diversification. Specifically, we demonstrated that we could 
engineer the production of the antibiotic pacidamycin bearing a 
7-chlorotryptophan, the halogen handle enabled synthetic 
diversification through Suzuki-Miyaura cross coupling chemistry 
to produce a new array of natural product analogues.7 
The requirement for halotryptophans has stimulated many 
synthetic studies. Since the first chemical synthesis of 7-
chlorotryptophan reported by Rydon and Tweddle,8 despite many 
advances, the best methods currently available are multi-step, 
lack generality or require specialised procedures. The use of the 
enzyme tryptophan synthase represents a convenient alternative, 
enabling the biotransformation of serine 2 and a substituted 
indole to give the corresponding substituted tryptophan (Scheme 
1). We have previously shown the utility of tryptophan synthase 
to convert haloindoles and nitroindoles to the corresponding 
tryptophans,9-11 and have even used this approach to access 
sterically demanding 7-iodotryptophan.11 Here, we report for the 
first time, the generation of 5,6-dihalotryptophans and 
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Scheme 1: Mechanism of tryptophan synthase showing how it may be 
harnessed to enable access to analogues such as L-7-alkynyltryptophan 7 
Tetrahedron 2 
alkynyltryptophans using tryptophan synthase. 
2. Tryptophan Synthase 
Naturally, the α-subunit of tryptophan synthase converts 
indole-3-glycerolphosphate to indole, with the loss of 
glyeraldehyde-3-phosphate, the β-subunit then utilizes this  
indole along with L-serine 2 and converts it to L-tryptophan, via 
the replacement reaction outlined in scheme 1,  using pyridoxal 
phosphate (PLP) as a co-factor. When substituted indoles are 
provided exogenously, the α-subunit is bypassed and the β-
subunit can be used to convert the indoles to the corresponding 
substituted-tryptophans. 
To further explore extension of substrate scope, we turned our 
attention to di-halotryptophans (Scheme 2). We subjected 
commercially-available 5,6-difluoroindole 8 to the tryptophan 
synthase reaction and were pleased to see the reaction proceed to 
give the corresponding 5,6-difluoro-L-tryptophan 9 in 52% yield 
(an average of 3 isolated yields) on a 2 mmol scale. The 
unreacted starting indole from the reaction could be recovered 
and subjected to additional rounds of reaction with tryptophan 
synthase. After 3 rounds of biotransformation with tryptophan 
synthase, 5,6-difluoro-L-tryptophan 9 could be isolated in a 
synthetically useful 71% yield on a 2 mmol scale.  
 
 
With commercially-available and sterically more demanding 5,6-
dichloroindole 10, the reaction proved more difficult than for the 
difluoro-derivative. 5,6-Dichloro-L-tryptophan 11 was isolated in 
7% yield (average of 4 isolated yields) after 2 mmol scale 
reaction with tryptophan synthase. Again, recycling of the 
unreacted starting material for 3 rounds with tryptophan synthase 
gave 25% isolated yield of 11. With the dihalotryptophans in 
hand, we decided to explore the possibility of using this reaction 
to process an alkynyl indole (Scheme 3). Incorporation of an 
alkyne “tag” into a small molecule, protein or natural product can 
enable selective diversification and tagging,12 through an alkyne-
azide cycloaddition reaction, commonly known as “click 
chemistry”.13 
 
We wanted to see if alkyne-substituted indoles were amenable to 
the tryptophan synthase reaction. 5-Ethynylindole 12 was 
synthesised from 5-iodoindole following literature procedure.14 
When substrate 12 was subjected to the tryptophan synthase 
reaction, alkyne-tryptophan 13 was isolated in low 2% yield 
(average of 3 isolated yields) on a 2 mmol scale.  
 
In an analogous manner to 12, 7-ethynylindole 4 was synthesized 
from 7-iodoindole. When subjected to the tryptophan synthase 
reaction on a small scale (0.9 mmol), the reaction worked with a 
much greater efficiency than for the 5-substituted indole and 
expected product 7 was isolated in 90% yield. We were unable to 
carry out the biotransformations on a larger scale and in triplicate 
due to limited availability of the starting 7-iodoindole. To our 
knowledge, the synthesis of alkynyl tryptophans 7 and 13 have 
not previously been reported. 
 
 
 
3. Conclusions 
We have expanded the scope of the tryptophan synthase reaction 
previously reported9-11 to include the synthesis of di-
halotryptophans and shown the first examples of the enzyme 
carrying out the biotransformation of alkyne-containing indoles. 
Although the conversion of 5-ethynylindole 13 was poor, 7-
ethynylindole 7 underwent surprisingly high conversion to the 
corresponding tryptophan. Perhaps reengineering of the enzyme 
might enable useful one step access to other terminal alkyne-
containing tryptophans. These new compounds show that 
tryptophan synthase can be used for the production of 
synthetically useful building blocks for subsequent chemical 
diversification or as useful platforms for precursor directed 
biosynthesis.  
4. Experimental 
4.1. General 
All reagents were purchased from commercial suppliers and were 
used without further purification unless otherwise stated. 
 
Proton NMR (1H), fluorine NMR (19F{1H}) and carbon NMR 
(13C) were recorded on a Bruker Advance 500 (500 MHz) or a 
Bruker Avance II (400 MHz). Using a deptq sequence or an 
HSQC experiment with multiplicity editing, the 13C NMR signals 
were assigned to CH3, CH2, CH and C. The NMR experiments 
were carried out in deuterochloroform (CDCl3), deuterated 
methanol (CD3OD), deuterated water (D2O) or deuterated DMSO 
(d6-DMSO). The chemical shifts (δ) are quoted in parts per 
million (ppm). Multiplicities are abbreviated as s, singlet; d, 
doublet; t, triplet; q, quartet; m, multiplet; b, broad for the 1H 
NMR, 19F{1H} NMR and 13C NMR spectra. Coupling constants 
are reported in Hertz (Hz).  
 
High and low resolution mass spectra were recorded at the 
EPSRC National Mass Spectrometry Service, Swansea or at the 
University of St Andrews on a Waters Micromass LCT time of 
flight mass spectrometer coupled to a Waters 2975 HPLC system 
or on an Orbitrap ELOS pro.  
Flash chromatography was performed using Davisil silica gel 
LC60A (40-63 micron). Thin layer chromatography (TLC) was 
performed using aluminium sheets of silica gel 60 F254 and was 
visualised under a Mineralight model UVGL-58 lamp (254 nm). 
The plates were developed with acidic methanolic vanillin 
solutions, ethanolic phosphomolybdic acid solutions or basic 
potassium permanganate solutions. 
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Purification of the ethynyltryptophans was carried out on a 
Biotage Isolera Four using reverse-phase SNAP C18 12 g 
column cartridges. The purification was carried out using 
water/methanol on the following gradient: 12 mL/min elution, 
2% methanol/water for 1.15 min, 2à15% methanol/water for 
1.15 min, 15% methanol/water for 5.15 min, 15à95% 
methanol/water for 15 min, 95% methanol/water for 3.45 min. 
The collection wavelength was set a 254 nm. Collection of the 
peaks occurring from approx. 4.3 min to 12.0 min gave the 
resulting ethynyltryptophans.  
Freeze drying was carried out on a Scanvac CoolSafeTM freeze 
dryer. 
Dialysis tubing cellulose membrane (average flat width 33 mm) 
was purchased from Sigma Aldrich. An approximately 20 cm 
length of tubing was immersed in water prior to use. One end 
was tied in a knot. The thawed cell lysate was inserted into the 
tied tubing using a pipette. Excess air was removed from inside 
the tubing and the other end was tied to give a cylinder of 
membrane sealed at both ends. The off-cuts of the knots were 
removed to give a tube length of approximately 5 cm for use in 
the reaction.  
4.1. L-5,6-Difluorotryptophan 9 
 
L-Serine 2 (0.262 g, 2.5 mmol, 1.25 eq) was dissolved in KH2PO4 
reaction buffer (0.1 M, pH 7.8, 95 mL). A solution of 5,6-
difluoro-1H-indole 8 (0.306 g, 2.0 mmol, 1.0 eq) in methanol (5 
mL) was added to the flask containing the reaction buffer with 
vigorous stirring. Tryptophan synthase cell lysate was thawed in 
a 37 °C water bath, then stored at 0 °C. The cell lysate (3 mL) 
was stored in a cellulose dialysis bag and added to the reaction 
flask. The biotransformation was carried out at 37 °C, shaking at 
180 rpm for 2 days. The aqueous layer was collected and washed 
with ethyl acetate (2 x 50 mL). The aqueous layer was 
concentrated to half its volume, then purified on C18 silica. The 
aqueous layer was loaded onto 30 g C18 silica, which was then 
washed with 200 mL water before elution of the product in 
methanol. The methanolic fractions were collected and the 
solvent was removed in vacuo. The residue was dissolved in 
water (50 mL) and lyophilised to give L-5,6-difluorotryptophan 8 
(245 mg, 51%) as a white solid; [α]D -12.4° (c 0.51, MeOH);  1H 
NMR (500 MHz, D2O) δ = 3.23 (1H, dd, J(H,H)= 15.5, 7.1 Hz, 
CHAHB), 3.28 (1H, dd, J(H,H)= 15.5, 5.4 Hz, CHAHB), 4.18 (1H, 
dd, J(H,H)= 6.9, 5.5 Hz, CH), 7.19 (2H, overlapping m, ArH), 
7.28 (1H, dd, J(H,F)= 11.2, 7.7 Hz, ArH); 13C NMR (125 MHz, 
D2O) δ = 25.6 (CH2), 53.3 (CH), 99.5 (d, J(C,F)= 21.7 Hz, CH), 
104.4 (d, J(C,F)= 19.5 Hz, CH), 106.6 (d, J(C,F)= 5.6 Hz, C), 
121.7 (d, J(C,F)= 8.1 Hz, C) 126.4 (d, J(C,F)= 3.5 Hz, CH), 
131.2 (d, J(C,F)= 10.9 Hz, C), 145.8, (dd, J(C,F)= 198.6, 15.0 
Hz, CF), 147.6 (dd, J(C,F)= 200.0, 15.3 Hz, C), 172.0 (CO); 
19F{1H} NMR (470 MHz, D2O) δ = -148.4 (d, J(F,F) = 21.1 Hz), 
-144.9 (d, J(F,F) - 21.1 Hz); HRMS (ESI): m/z calcd for 
C11H11F2N2O2+ [M+H]+: 241.0783; found 241.0782. 
 
The reaction was repeated two more times to give L-5,6-
difluorotryptophan 9 (307 mg, 55%) and (233 mg, 49%). Over 
three runs, this gave an average yield of 52%. 
 
4.2. L-5,6-Dichlorotryptophan 11 
 
Using the biotransformation procedure reported above for 9, 5,6-
dichloro-1H-indole 10 (0.372 g, 2.0 mmol, 1.0 eq) gave 5,6-
dichlorotryptophan 11 (33 mg, 6%) as a white solid; [α]D -14.7° 
(c 0.53, MeOH);  1H NMR (500 MHz, D2O) δ = 3.21 (1H, dd, 
J(H,H)= 15.5, 7.1 Hz, CHAHB), 3.28 (1H, dd, J(H,H)= 15.3, 5.0 
Hz, CHAHB), 4.13 (1H, dd, J(H,H)= 7.2, 5.3 Hz, CH), 7.18 (1H, 
s, ArH), 7.44 (1H, s, ArH), 7.57 (1H, s, ArH); 13C NMR (125 
MHz, D2O) δ = 25.7 (CH2), 53.5 (CH), 106.3 (C), 113.0 (CH), 
118.9 (CH), 122.4 (C), 124.7 (C), 126.3 (C), 127.1 (CH), 135.0 
(C), 172.3 (CO); HRMS (ESI): m/z calcd for C11H11Cl2N2O2+ 
[M+H]+: 273.0192; found: 273.0190. 
 
The reaction was repeated three more times to give L-5,6-
dichlorotryptophan 11 (68 mg, 12%), (30 mg, 5%) and (26 mg, 
5%). Over four runs, this gave an average yield of 7%. 
 
 
4.3. tert-Butyl 5-iodo-1H-indole-1-carboxylate 
 
Di-tert-butyl dicarbonate (3.4 mL, 14.8 mmol, 1.2 eq) was added 
to a solution of 5-iodoindole (3 g, 12.3 mmol, 1.0 eq) and 4-
DMAP (0.3 g, 2.5 mmol, 0.2 eq) in DCM (100 mL) at r.t. under 
nitrogen and stirred for 2.5 h. The solvent was removed in vacuo. 
Purification by column chromatography using silica gel (1:19 
ethyl acetate:hexane) gave tert-butyl 5-iodo-1H-indole-1-
carboxylate (4.2 g, 100%) as a white solid; 1H NMR (500 MHz, 
CDCl3) δ = 1.68 (9H, s, CH3), 6.50 (1H, dd, J(H,H)= 3.7, 0.6 Hz, 
ArH), 7.56 (1H, d, J(H,H)= 3.7Hz, ArH), 7.58 (1H, dd, J(H,H)= 
8.7, 1.8 Hz, ArH), 7.90 (1H, d, J(H,H)= 1.8 Hz, ArH), 7.93 (1H, 
bd, J(H,H)= 8.7 Hz, ArH); 13C NMR (125 MHz, CDCl3) δ = 28.3 
(CH3), 84.3 (C), 86.8 (C), 106.4 (CH), 117.2 (CH), 126.8 (CH), 
129.9 (CH), 132.8 (CH), 133.0 (C), 134.7 (C), 149.6 (CO). 
 
4.4. 5-Ethynyl-1H-indole 12 
 
Ethynyltrimethylsilane (2.6 mL, 18.5 mmol, 1.5 eq) was added to 
a solution of bis(triphenylphosphine)palladium (II) dichloride 
(216 mg, 0.3 mmol, 2.5 mol%), copper (I) iodide (117 mg, 0.6 
mmol, 5 mol%) and tert-butyl 5-iodo-1H-indole-1-carboxylate 
(4.22 g, 12.3 mmol, 1.0 eq) in triethylamine (100 mL) at r.t under 
nitrogen and stirred for 18 h. The reaction mixture was filtered 
through celite and the solvent was removed in vacuo. The residue 
was dissolved in methanol (100 mL) and potassium carbonate 
(3.4 g, 24.6 mmol, 2.0 eq) was added. The reaction was stirred at 
r.t. for 4 h. The reaction mixture was diluted with water (200 mL) 
and extracted with diethyl ether (2 x 200 mL). The combined 
organic layers were dried over anhydrous sodium sulfate and the 
solvent removed in vacuo. Purification by column 
chromatography using silica gel (1:19 ethyl acetate:hexane) gave 
5-ethynyl-1H-indole 12 (1.04 g, 60% over 2 steps) as a pale 
brown oil; 1H NMR (500 MHz, CDCl3) δ = 3.01 (1H, s, CH), 
6.56 (1H, dd, J(H,H)= 3.2, 2.0 Hz, ArH), 7.25 (1H, dd, J(H,H)= 
3.2, 2.4 Hz, ArH), 7.34-7.35 (2H, m, ArH), 7.84-7.85 (1H, m, 
ArH), 8.24 (1H, bs, NH); 13C NMR (125 MHz, CDCl3) δ = 74.8 
(CH), 85.5 (C), 103.1 (CH), 111.3 (CH), 113.4 (C), 125.4 (CH), 
125.5 (CH), 126.2 (CH), 127.8 (C), 135.8 (C); HRMS (EI): m/z 
calcd for C10H7N1+• [M]+•: 141.0578; found: 141.0583. 
 
4.5. L-5-Ethynyltryptophan 13 
 
L-Serine 2 (0.262 g, 2.5 mmol, 1.25 eq) was dissolved in KH2PO4 
reaction buffer (0.1 M, pH 7.8, 95 mL). A solution of 5-ethynyl-
1H-indole 12 (0.282 g, 2.0 mmol, 1.0 eq) in acetonitrile (5 mL) 
was added to the flask containing the reaction buffer with 
vigorous stirring. Tryptophan synthase cell lysate was thawed in 
a 37 °C water bath, then stored at 0 °C. The cell lysate (3 mL) 
was stored in a cellulose dialysis bag and added to the reaction 
flask. The biotransformation was carried out at 37 °C, shaking at 
180 rpm for 2 days. The aqueous layer was collected and washed 
with ethyl acetate (2 x 50 mL). The aqueous layer was 
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concentrated to half its volume, then purified using a Biotage 
column. The aqueous layer was loaded onto a SNAP C18 12 g 
cartridge, then 200 mL water was eluted from the cartridge 
before loading onto the Biotage Isolera 4 for the purification 
gradient. The fractions were collected and the solvent was 
removed in vacuo. The residue was dissolved in water (50 mL) 
and lyophilised to give L-5-ethynyltryptophan 13 (8.3 mg, 1.8%) 
as a white solid; [α]D +64.7° (c 0.37, MeOH);  1H NMR (500 
MHz, CD3OD) δ = 3.13 (1H, dd, J(H,H)= 15.1, 9.0 Hz, CHAHB), 
3.26 (1H, s, CH), 3.44-3.48 (1H, m, CHAHB), 3.81 (1H, dd, 
J(H,H)= 9.0, 4.2 Hz, CH), 7.22 (1H, dd, J(H,H)= 8.5, 1.5 Hz, 
ArH), 7.24 (1H, s, ArH), 7.32 (1H, dd, J(H,H)= 8.4, 0.5 Hz, 
ArH), 7.91 (1H, bs, ArH); 13C NMR (125 MHz, CD3OD) δ = 
28.6 (CH2), 56.8 (CH), 75.6 (CH), 86.4 (C), 110.2 (C), 112.5 
(CH), 114.1 (C), 124.0 (CH), 126.4 (CH), 126.5 (CH), 128.4 (C), 
138.2 (C), 151.0 (CO); MS (ESI) 229 (100) [M+H]+, 212 (90); 
HRMS: m/z calcd for C13H13N2O2 [M+H]+: 229.0972; found: 
229.0970. 
 
The reaction was repeated two more times to give L-5-
ethynyltryptophan 13 (5.9 mg, 1.3%) and (7.2 mg, 1.6%). Over 
three runs, this gave an average yield of 1.6%. 
 
4.6. tert-Butyl 7-iodo-1H-indole-1-carboxylate 
 
Following the procedure reported above, 7-iodoindole was 
converted to tert-butyl 7-iodo-1H-indole-1-carboxylate; 1H NMR 
(500 MHz, CDCl3) δ = 1.68 (9H, s, CH3), 6.54 (1H, d, J(H,H)= 
3.7 Hz, ArH), 6.95 (1H, dd, J(H,H)= 7.7, 7.7 Hz, ArH), 7.51 (1H, 
d, J(H,H)= 3.7 Hz, ArH), 7.56 (1H, dd, J(H,H)= 7.7, 0.9 Hz, 
ArH), 7.85 (1H, dd, J(H,H)= 7.7, 0.8 Hz, ArH); 13C NMR (125 
MHz, CDCl3) δ = 28.3 (CH3), 78.6 (C), 84.4 (C), 107.1 (CH), 
121.1 (CH), 124.6 (CH), 129.3 (CH), 133.8 (C), 137.2 (CH), 
137.7 (C), 148.3 (CO); HRMS (ESI): m/z calcd for C13H18I1N2O2+ 
[M+NH4]+: 361.0407; found: 361.0408. 
 
4.7. 7-Ethynyl-1H-indole 4 
 
Following the procedure reported above, tert-butyl 7-iodo-1H-
indole-1-carboxylate was converted to 7-ethynyl-1H-indole 4 
(0.15 g, 70%) as a brown oil; 1H NMR (500 MHz, CDCl3) δ = 
3.42 (1H, s, CH), 6.62 (1H, dd, J(H,H)= 3.1, 2.2 Hz, ArH), 7.12 
(1H, dd, J(H,H)= 7.9, 7.3 Hz, ArH), 7.27-7.28 (1H, m, ArH), 
7.41 (1H, d, J(H,H)= 7.3 Hz, ArH), 7.70 (1H, d, J(H,H)= 7.9 Hz, 
ArH), 8.51 (1H, bs, NH); 13C NMR (125 MHz, CDCl3) δ = 80.5 
(C), 81.4 (CH), 103.5 (CH), 105.0 (C), 119.9 (CH), 122.3 (CH),  
124.7 (CH), 126.1 (CH), 127.6 (C), 137.1 (C); HRMS (EI): m/z 
calcd for C10H7N1+• [M]+•: 141.0578; found: 141.0582. 
 
4.8. L-7-Ethynyltryptophan 7 
 
Using the procedure reported above for 13, 7-ethynyl-1H-indole 
4 (0.128 g, 0.9 mmol, 1.0 eq) gave L-7-ethynyltryptophan 7 (0.19 
g, 90%) as a white solid; [α]D +64.2° (c 0.55, MeOH);  1H NMR 
(500 MHz, d6-DMSO) δ = 2.83 (1H, bs, CHAHB), 3.20 (1H, bd, 
J(H,H)= 13.2 Hz, CHAHB), 3.32 (1H, bs, CH), 4.41 (1H, s, CH), 
6.96 (1H, dd, J(H,H)= 7.6, 7.5 Hz, ArH), 7.19-7.20 (2H, m, 
ArH), 7.61 (1H, bd, J(H,H)= 7.8 Hz, ArH), 11.03 (1H, bs, NH); 
1H NMR (500 MHz, CD3OD) δ = 3.05-3.10 (1H, m, CHAHB), 
3.39-3.43 (1H, m, CHAHB), 3.72-3.74 (1H, m, CH), 3.74 (1H, s, 
CH), 7.01 (1H, dd, J(H,H)= 7.8, 7.5 Hz, ArH), 7.24 (1H, s, ArH), 
7.25 (1H, d, J(H,H)= 7.3 Hz, ArH), 7.75 (1H, dd, J(H,H)= 8.0, 
0.8 Hz, ArH); 13C NMR (125 MHz, CD3OD) δ = 30.0 (CH2), 
57.1 (CH), 80.8 (C), 81.2 (C), 82.2 (CH), 106.6 (C), 111.6 (C), 
119.8 (CH), 120.9 (CH), 125.7 (CH), 126.6 (CH), 128.7 (C), 
138.9 (C), 177.5 (CO); MS (ESI) 229 (100) [M+H]+; HRMS: m/z 
calcd for C13H13N2O2 [M+H]+: 229.0972; found: 229.0969. 
 
L-7-Ethynyltryptophan 7 exhibited some unusual NMR behavior; 
When the 1H NMR spectrum was recorded in CD3OD, the signal 
for the alkyne proton at δH 3.74 ppm gave a decreased integral to 
what was expected (0.2 rather than 1.0). Increasing the relaxation 
time of the NMR spectrum (from 1 s to 4 s) did not increase the 
intensity of the signal as may have been expected, but removed 
the signal for the alkyne proton entirely. When the 13C NMR was 
recorded, the alkyne signals were visible at δC 81.21 and 82.23 
ppm, along with a new, broader peak at δC 80.76 ppm. When the 
spectrum was recorded in d6-DMSO, the alkyne proton signal 
was apparent at δH 4.41 ppm and had no decrease in the NMR 
integration, relative to the aromatic protons. However, when the 
13C NMR was recorded in d6-DMSO, two alkyne signals were 
observed (at δC 80.82 and 84.09 ppm), but this time, the carbon 
signals for the tryptophan side chain has disappeared. We are 
unsure what the cause of this unusual NMR behaviour. L-5-
ethynyltryptophan 13 exhibited no such behaviour in the NMR 
spectra. 
 
Enantiopurity analysis 
The enantiopurity of the generated tryptophan derivatives was 
analysed using Marfey’s Reagent (1-fluoro-2,4-dinitrophenyl-5-
L-alanine amide, FDAA).  
The tryptophan was dissolved in HCl solution (1M, 10 mg/mL). 
A vial containing the tryptophan (50 µL), FDAA (1% w/v in 
actone, 100 µL) and NaHCO3 solution (1M, 70 µL) was mixed 
thoroughly and incubated at 37 °C for 1 h. The reaction mixture 
was diluted (10 µL in 490 µL water) and centrifuged (13,000 
rpm, 5 min) before UPLC analysis.  
 
The UPLC analysis was carried out in acetonitrile/0.1% TFA in 
water at a gradient of 20% acetonitrile to 90% acetonitrile over 
4.7 minutes. A 3:1 mixture of L-tryptophan to D-tryptophan was 
used as a standard. Two blank runs using acetone were conducted 
between each tryptophan sample.  In all of the tryptophans 
analysed (with the exception of L-5-ethynyltryptophan 13), only a 
single peak for the L-enantiomer was observed (see supporting 
information). In the case of L-5-ethynyltryptophan 13, 
decomposition appeared to occur when subjected to the analysis 
conditions. Given the similar optical rotations between 7 and 13, 
we are confident that no racemization of the stereocentre had 
occurred during the biotransformation reaction.  
 
Use of DL-serine 
The biotransformation was carried out on indole using either L-
serine (2.5 eq) or DL-serine (2.5 eq). The number of equivalents 
of serine was doubled from a normal biotransformation to ensure 
that enough L-serine was present for the reaction to go to full 
conversion (for the case of DL-serine).  In both reactions, 
comparable quantities of L-tryptophan were isolated; L-
tryptophan (0.120 g, 29%) was isolated from the reaction with L-
serine, L-tryptophan (0.153 g, 37%) was isolated from the 
reaction with DL-serine. Analysis of the enantiopurity of the 
tryptophans using Marfey’s reagent showed that in both cases, 
only L-typtophan was produced. The use of DL-serine is possible 
in the reaction and shows no detriment to yield or enantiopurity. 
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